Growth Metrics

Vericel (VCEL) EPS (Weighted Average and Diluted) (2018 - 2025)

Historic EPS (Weighted Average and Diluted) for Vericel (VCEL) over the last 11 years, with Q3 2025 value amounting to $0.1.

  • Vericel's EPS (Weighted Average and Diluted) rose 60000.0% to $0.1 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.25, marking a year-over-year increase of 25714.29%. This contributed to the annual value of $0.2 for FY2024, which is 38643.85% up from last year.
  • Latest data reveals that Vericel reported EPS (Weighted Average and Diluted) of $0.1 as of Q3 2025, which was up 60000.0% from -$0.01 recorded in Q2 2025.
  • In the past 5 years, Vericel's EPS (Weighted Average and Diluted) ranged from a high of $0.38 in Q4 2024 and a low of -$0.23 during Q1 2025
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.08 (2021), whereas its average is -$0.03.
  • As far as peak fluctuations go, Vericel's EPS (Weighted Average and Diluted) plummeted by 23750.0% in 2021, and later skyrocketed by 60000.0% in 2025.
  • Vericel's EPS (Weighted Average and Diluted) (Quarter) stood at $0.1 in 2021, then increased by 30.0% to $0.13 in 2022, then soared by 107.69% to $0.27 in 2023, then skyrocketed by 41.95% to $0.38 in 2024, then tumbled by 73.91% to $0.1 in 2025.
  • Its last three reported values are $0.1 in Q3 2025, -$0.01 for Q2 2025, and -$0.23 during Q1 2025.